| # | Date / Author / Journal | LCS | GCS | LCR | CR
|
|---|
| 101 | 24959 Jellinger KAJOURNAL OF CELLULAR AND MOLECULAR MEDICINE. 2010 MAR; 14 (3): 457-487
| 0 | 0 | 169 | 460
|
| 102 | 26895 Uversky VNCHEMICAL REVIEWS. 2011 FEB; 111 (2): 1134-1166
| 0 | 0 | 89 | 459
|
| 103 | 2366 PRANZATELLI MRCLINICAL NEUROPHARMACOLOGY. 1992 JUN; 15 (3): 186-228
| 0 | 89 | 3 | 456
|
| 104 | 22662 George JL, Mok S, Moses D, Wilkins S, Bush AI, et al.CURRENT NEUROPHARMACOLOGY. 2009 MAR; 7 (1): 9-36
| 2 | 5 | 96 | 454
|
| 105 | 21894 Saavedra A, Baltazar G, Duarte EPPROGRESS IN NEUROBIOLOGY. 2008 NOV; 86 (3): 186-215
| 1 | 10 | 36 | 453
|
| 106 | 9394 Bredel MBRAIN RESEARCH REVIEWS. 2001 APR; 35 (2): 161-204
| 2 | 69 | 11 | 452
|
| 107 | 5302 Ross CA, Margolis RL, Rosenblatt A, Ranen NG, Becher MW, et al.MEDICINE. 1997 SEP; 76 (5): 305-338
| 14 | 61 | 2 | 451
|
| 108 | 20774 Abdipranoto A, Wu S, Stayte S, Vissel BCNS & NEUROLOGICAL DISORDERS-DRUG TARGETS. 2008 APR; 7 (2): 187-210
| 3 | 12 | 35 | 450
|
| 109 | 26175 Cauwe B, Opdenakker GCRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY. 2010 OCT; 45 (5): 351-423
| 0 | 0 | 12 | 441
|
| 110 | 11720 Herrmann H, Hesse M, Reichenzeller M, Aebi U, Magin TMINTERNATIONAL REVIEW OF CYTOLOGY - A SURVEY OF CELL BIOLOGY, VOL 223. 2003; 223: 83-+
| 3 | 104 | 35 | 439
|
| # | Date / Author / Journal | LCS | GCS | LCR | CR
|
|---|
| 111 | 20595 Cozzolino M, Ferri A, Carri MTANTIOXIDANTS & REDOX SIGNALING. 2008 MAR; 10 (3): 405-443
| 8 | 39 | 79 | 439
|
| 112 | 20982 Turner BJ, Talbot KPROGRESS IN NEUROBIOLOGY. 2008 MAY; 85 (1): 94-134
| 31 | 80 | 66 | 438
|
| 113 | 23040 Tandon R, Nasrallah HA, Keshavan MSSCHIZOPHRENIA RESEARCH. 2009 MAY; 110 (1-3): 1-23
| 0 | 21 | 5 | 433
|
| 114 | 7843 Lazarov NEMESENCEPHALIC TRIGEMINAL NUCLEUS IN THE CAT. 2000; 153: 1-+
| 1 | 14 | 11 | 431
|
| 115 | 16600 Mattiasson G, Sullivan PGANTIOXIDANTS & REDOX SIGNALING. 2006 JAN-FEB; 8 (1-2): 1-38
| 1 | 43 | 7 | 431
|
| 116 | 17211 Gaggelli E, Kozlowski H, Valensin D, Valensin GCHEMICAL REVIEWS. 2006 JUN; 106 (6): 1995-2044
| 17 | 182 | 61 | 430
|
| 117 | 335 ROSENKILDE CEACTA PHYSIOLOGICA SCANDINAVICA. 1983; : 1-58
| 0 | 0 | 23 | 429
|
| 118 | 8535 Buee L, Bussiere T, Buee-Scherrer V, Delacourte A, Hof PRBRAIN RESEARCH REVIEWS. 2000 AUG; 33 (1): 95-130
| 400 | 555 | 218 | 429
|
| 119 | 4053 BRUNELLO N, MASOTTO C, STEARDO L, MARKSTEIN R, RACAGNI GNEUROPSYCHOPHARMACOLOGY. 1995 NOV; 13 (3): 177-213
| 3 | 148 | 4 | 428
|
| 120 | 6979 Harrison PJBRAIN. 1999 APR; 122: 593-624
| 125 | 808 | 53 | 428
|
| # | Date / Author / Journal | LCS | GCS | LCR | CR
|
|---|
| 121 | 8439 Cacabelos R, Alvarez A, Lombardi A, Fernandez-Novoa L, Corzo L, et al.DRUGS OF TODAY. 2000 JUL; 36 (7): 415-499
| 5 | 44 | 21 | 428
|
| 122 | 22373 Biran Y, Masters CL, Barnham KJ, Bush AI, Adlard PAJOURNAL OF CELLULAR AND MOLECULAR MEDICINE. 2009 JAN; 13 (1): 61-86
| 4 | 11 | 87 | 427
|
| 123 | 19351 Okouchi M, Ekshyyan O, Maracine M, Aw TY, Calabrese V, et al.ANTIOXIDANTS & REDOX SIGNALING. 2007 AUG; 9 (8): 1059-1096
| 4 | 44 | 39 | 424
|
| 124 | 20113 Surguchov AINTERNATIONAL REVIEW OF CELL AND MOLECULAR BIOLOGY, VOL 270. 2008; 270: 225-317
| 6 | 12 | 320 | 420
|
| 125 | 15327 Wobus AM, Boheler KRPHYSIOLOGICAL REVIEWS. 2005 APR; 85 (2): 635-678
| 5 | 241 | 8 | 419
|
| 126 | 25430 Uversky VN, Dunker AKBIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS. 2010 JUN; 1804 (6): 1231-1264
| 1 | 21 | 25 | 418
|
| 127 | 9005 Halliwell BDRUGS & AGING. 2001; 18 (9): 685-716
| 37 | 422 | 37 | 414
|
| 128 | 22502 Orellana JA, Saez PJ, Shoji KF, Schalper KA, Palacios-Prado N, et al.ANTIOXIDANTS & REDOX SIGNALING. 2009 FEB; 11 (2): 369-399
| 0 | 19 | 15 | 412
|
| 129 | 20031 Crimmins E, Vasunilashorn S, Kim JK, Alley DADVANCES IN CLINICAL CHEMISTRY, VOL 46. 2008; 46: 161-216
| 0 | 13 | 9 | 408
|
| 130 | 18250 Veitch NCNATURAL PRODUCT REPORTS. 2007; 24 (2): 417-464
| 0 | 30 | 1 | 406
|
| # | Date / Author / Journal | LCS | GCS | LCR | CR
|
|---|
| 131 | 9011 Greenacre SAB, Ischiropoulos HFREE RADICAL RESEARCH. 2001; 34 (6): 541-581
| 39 | 272 | 8 | 404
|
| 132 | 21170 Wang JZ, Liu FPROGRESS IN NEUROBIOLOGY. 2008 JUN; 85 (2): 148-175
| 22 | 45 | 259 | 404
|
| 133 | 13797 Poli G, Leonarduzzi G, Biasi F, Chiarpotto ECURRENT MEDICINAL CHEMISTRY. 2004 MAY; 11 (9): 1163-1182
| 2 | 163 | 4 | 403
|
| 134 | 12467 Dev KK, Hofele K, Barbieri S, Buchman VL, van der Putten HNEUROPHARMACOLOGY. 2003 JUL; 45 (1): 14-44
| 76 | 93 | 274 | 402
|
| 135 | 20922 Murrey HE, Hsieh-Wilson LCCHEMICAL REVIEWS. 2008 MAY; 108 (5): 1708-1731
| 0 | 24 | 15 | 402
|
| 136 | 11785 Palomo T, Beninger RJ, Kostrzewa RM, Archer TNEUROTOXICITY RESEARCH. 2003; 5 (1-2): 1-26
| 2 | 24 | 28 | 401
|
| 137 | 20039 Jahn U, Galano JM, Durand TANGEWANDTE CHEMIE-INTERNATIONAL EDITION. 2008; 47 (32): 5894-5955
| 1 | 28 | 28 | 401
|
| 138 | 26891 Yirmiya R, Goshen IBRAIN BEHAVIOR AND IMMUNITY. 2011 FEB; 25 (2): 181-213
| 0 | 0 | 13 | 400
|
| 139 | 11029 Mattson MP, Chan SL, Duan WZPHYSIOLOGICAL REVIEWS. 2002 JUL; 82 (3): 637-672
| 26 | 169 | 50 | 399
|
| 140 | 5577 Smith MAINTERNATIONAL REVIEW OF NEUROBIOLOGY, VOL 42. 1998; 42: 1-54
| 32 | 122 | 51 | 397
|
| # | Date / Author / Journal | LCS | GCS | LCR | CR
|
|---|
| 141 | 22412 Altar CA, Vawter MP, Ginsberg SDNEUROPSYCHOPHARMACOLOGY. 2009 JAN; 34 (1): 18-54
| 4 | 23 | 62 | 397
|
| 142 | 9904 Tiedemann H, Asashima M, Grunz H, Knochel WDEVELOPMENT GROWTH & DIFFERENTIATION. 2001 OCT; 43 (5): 469-502
| 0 | 30 | 3 | 394
|
| 143 | 20527 Rezai AR, Machado AG, Deogaonkar M, Azmi H, Kubu C, et al.NEUROSURGERY. 2008 FEB; 62 (2): 809-838
| 0 | 14 | 15 | 394
|
| 144 | 2437 WINKLER H, FISCHERCOLBRIE RNEUROSCIENCE. 1992 AUG; 49 (3): 497-528
| 33 | 499 | 72 | 392
|
| 145 | 14925 Harrison PJ, Weinberger DRMOLECULAR PSYCHIATRY. 2005 JAN; 10 (1): 40-68
| 85 | 632 | 49 | 392
|
| 146 | 19893 [Anon]AMERICAN JOURNAL OF PSYCHIATRY. 2007 DEC; 164 (12): 5-56
| 0 | 0 | 11 | 392
|
| 147 | 1552 TITMUS MJ, FABER DSPROGRESS IN NEUROBIOLOGY. 1990; 35 (1): 1-51
| 2 | 183 | 4 | 391
|
| 148 | 21104 Uversky VNCURRENT ALZHEIMER RESEARCH. 2008 JUN; 5 (3): 260-287
| 7 | 25 | 119 | 391
|
| 149 | 16569 Walterfang M, Wood SJ, Velakoulis D, Pantelis CNEUROSCIENCE AND BIOBEHAVIORAL REVIEWS. 2006; 30 (7): 918-948
| 1 | 38 | 28 | 390
|
| 150 | 6578 Rossner S, Ueberham U, Schliebs R, Perez-Polo JR, Bigl VPROGRESS IN NEUROBIOLOGY. 1998 DEC; 56 (5): 541-569
| 33 | 122 | 43 | 384
|
| # | Date / Author / Journal | LCS | GCS | LCR | CR
|
|---|
| 151 | 19000 Zana M, Janka Z, Kalman JNEUROBIOLOGY OF AGING. 2007 MAY; 28 (5): 648-676
| 2 | 20 | 43 | 384
|
| 152 | 20764 McGrogan BT, Gilmartin B, Camey DN, McCann ABIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER. 2008 APR; 1785 (2): 96-132
| 0 | 69 | 15 | 384
|
| 153 | 22724 Xu SBPROGRESS IN RETINAL AND EYE RESEARCH. 2009 MAR; 28 (2): 87-116
| 0 | 3 | 6 | 384
|
| 154 | 18427 Carter CJNEUROCHEMISTRY INTERNATIONAL. 2007 JAN; 50 (1): 12-38
| 5 | 50 | 19 | 383
|
| 155 | 450 STERIADE M, DESCHENES MBRAIN RESEARCH REVIEWS. 1984; 8 (1): 1-63
| 9 | 495 | 7 | 381
|
| 156 | 19077 Gillet JP, Efferth T, Remacle JBIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER. 2007 JUN; 1775 (2): 237-262
| 0 | 52 | 7 | 381
|
| 157 | 554 SARTER M, MARKOWITSCH HJBEHAVIORAL NEUROSCIENCE. 1985; 99 (2): 342-380
| 3 | 226 | 18 | 380
|
| 158 | 20706 Marino MJ, Knutsen LJS, Williams MJOURNAL OF MEDICINAL CHEMISTRY. 2008 MAR 13; 51 (5): 1077-1107
| 1 | 13 | 16 | 379
|
| 159 | 13794 Halliwell B, Whiteman MBRITISH JOURNAL OF PHARMACOLOGY. 2004 MAY; 142 (2): 231-255
| 6 | 414 | 20 | 377
|
| 160 | 20515 Nakka VP, Gusain A, Mehta SL, Raghubir RMOLECULAR NEUROBIOLOGY. 2008 FEB; 37 (1): 7-38
| 1 | 23 | 12 | 377
|
| # | Date / Author / Journal | LCS | GCS | LCR | CR
|
|---|
| 161 | 22650 Maalouf M, Rho JM, Mattson MPBRAIN RESEARCH REVIEWS. 2009 MAR; 59 (2): 293-315
| 0 | 27 | 21 | 376
|
| 162 | 14915 Thompson HJ, Lifshitz J, Marklund N, Grady MS, Graham DI, et al.JOURNAL OF NEUROTRAUMA. 2005 JAN; 22 (1): 42-75
| 47 | 105 | 90 | 375
|
| 163 | 21898 Leung MCK, Williams PL, Benedetto A, Au C, Helmcke KJ, et al.TOXICOLOGICAL SCIENCES. 2008 NOV; 106 (1): 5-28
| 3 | 42 | 24 | 375
|
| 164 | 11289 Moosmann B, Behl CEXPERT OPINION ON INVESTIGATIONAL DRUGS. 2002 OCT; 11 (10): 1407-1435
| 13 | 66 | 45 | 373
|
| 165 | 17358 Warrington KH, Herzog RWHUMAN GENETICS. 2006 JUL; 119 (6): 571-603
| 0 | 65 | 6 | 373
|
| 166 | 20986 Schaeffer EL, Gattaz WFPSYCHOPHARMACOLOGY. 2008 MAY; 198 (1): 1-27
| 2 | 18 | 32 | 373
|
| 167 | 18249 Altmann KH, Gertsch JNATURAL PRODUCT REPORTS. 2007; 24 (2): 327-357
| 1 | 68 | 3 | 372
|
| 168 | 21449 Serretti A, Mandelli LMOLECULAR PSYCHIATRY. 2008 AUG; 13 (8): 742-771
| 2 | 46 | 6 | 369
|
| 169 | 23377 Robles ANEUROLOGIA. 2009 JUL-AUG; 24 (6): 399-418
| 0 | 0 | 147 | 369
|
| 170 | 20103 Liberski PPFOLIA NEUROPATHOLOGICA. 2008; 46 (2): 93-116
| 0 | 1 | 19 | 368
|
| # | Date / Author / Journal | LCS | GCS | LCR | CR
|
|---|
| 171 | 25189 De Strooper BPHYSIOLOGICAL REVIEWS. 2010 APR; 90 (2): 465-494
| 1 | 12 | 80 | 367
|
| 172 | 14756 Casetta I, Govoni V, Granieri ECURRENT PHARMACEUTICAL DESIGN. 2005; 11 (16): 2033-2052
| 3 | 40 | 47 | 366
|
| 173 | 26518 Nassif M, Matus S, Castillo K, Hetz CANTIOXIDANTS & REDOX SIGNALING. 2010 DEC; 13 (12): 1955-1989
| 0 | 0 | 63 | 365
|
| 174 | 19711 Ke Y, Qian ZMPROGRESS IN NEUROBIOLOGY. 2007 OCT; 83 (3): 149-173
| 4 | 21 | 22 | 362
|
| 175 | 10718 Valverde FREVISTA DE NEUROLOGIA. 2002 APR 16; 34 (8): 758-780
| 0 | 10 | 18 | 361
|
| 176 | 22640 Martinez MC, Andriantsitohaina RANTIOXIDANTS & REDOX SIGNALING. 2009 MAR; 11 (3): 669-702
| 1 | 8 | 27 | 361
|
| 177 | 8710 Slominski A, Wortsman JENDOCRINE REVIEWS. 2000 OCT; 21 (5): 457-487
| 0 | 210 | 4 | 360
|
| 178 | 23668 Bauer PO, Nukina NJOURNAL OF NEUROCHEMISTRY. 2009 SEP; 110 (6): 1737-1765
| 6 | 19 | 90 | 360
|
| 179 | 992 PERENTES E, RUBINSTEIN LJARCHIVES OF PATHOLOGY & LABORATORY MEDICINE. 1987 SEP; 111 (9): 796-812
| 36 | 186 | 25 | 359
|
| 180 | 12229 Fallon JH, Opole IO, Potkin SGCLINICAL NEUROSCIENCE RESEARCH. 2003 MAY; 3 (1-2): 77-107
| 2 | 16 | 29 | 359
|
| # | Date / Author / Journal | LCS | GCS | LCR | CR
|
|---|
| 181 | 13300 Phillis JW, O'Regan MHBRAIN RESEARCH REVIEWS. 2004 JAN; 44 (1): 13-47
| 4 | 53 | 5 | 359
|
| 182 | 20370 Freund-Michel V, Frossard NPHARMACOLOGY & THERAPEUTICS. 2008 JAN; 117 (1): 52-76
| 1 | 32 | 18 | 359
|
| 183 | 25817 Heneka MT, O'Banion MK, Terwel D, Kummer MPJOURNAL OF NEURAL TRANSMISSION. 2010 AUG; 117 (8): 919-947
| 0 | 0 | 31 | 359
|
| 184 | 19907 Lacor PNCURRENT GENOMICS. 2007 DEC; 8 (8): 486-508
| 2 | 5 | 80 | 358
|
| 185 | 18562 Woulfe JMNEUROPATHOLOGY AND APPLIED NEUROBIOLOGY. 2007 FEB; 33 (1): 2-42
| 7 | 15 | 122 | 357
|
| 186 | 14920 Dalle-Donne I, Scaloni A, Giustarini D, Cavarra E, Tell G, et al.MASS SPECTROMETRY REVIEWS. 2005 JAN-FEB; 24 (1): 55-99
| 10 | 120 | 20 | 356
|
| 187 | 25448 Manolagas SCENDOCRINE REVIEWS. 2010 JUN; 31 (3): 266-300
| 0 | 11 | 3 | 354
|
| 188 | 4143 Heidemann SRINTERNATIONAL REVIEW OF CYTOLOGY - A SURVEY OF CELL BIOLOGY, VOL 165. 1996; 165: 235-296
| 4 | 58 | 22 | 353
|
| 189 | 17685 Seeman P, Schwarz J, Chen JF, Szechtman H, Perreault M, et al.SYNAPSE. 2006 SEP 15; 60 (4): 319-346
| 0 | 112 | 11 | 353
|
| 190 | 18049 Bogoyevitch MA, Kobe BMICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS. 2006 DEC; 70 (4): 1061-+
| 3 | 90 | 9 | 353
|
| # | Date / Author / Journal | LCS | GCS | LCR | CR
|
|---|
| 191 | 23250 Duyckaerts C, Delatour B, Potier MCACTA NEUROPATHOLOGICA. 2009 JUL; 118 (1): 5-36
| 15 | 29 | 116 | 353
|
| 192 | 4850 Bedell MA, Largaespada DA, Jenkins NA, Copeland NGGENES & DEVELOPMENT. 1997 JAN 1; 11 (1): 11-43
| 0 | 91 | 6 | 352
|
| 193 | 4986 Ray D, Melmed SENDOCRINE REVIEWS. 1997 APR; 18 (2): 206-228
| 0 | 166 | 2 | 352
|
| 194 | 4774 Kisilevsky R, Fraser PECRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY. 1997; 32 (5): 361-404
| 4 | 73 | 24 | 350
|
| 195 | 20266 Duyckaerts C, Potier MC, Delatour BACTA NEUROPATHOLOGICA. 2008 JAN; 115 (1): 5-38
| 29 | 63 | 89 | 350
|
| 196 | 23769 Mangialasche F, Polidori MC, Monastero R, Ercolani S, Camarda C, et al.AGEING RESEARCH REVIEWS. 2009 OCT; 8 (4): 285-305
| 2 | 15 | 71 | 350
|
| 197 | 292 KOMPF DFORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE. 1982; 50 (5): 143-164
| 1 | 7 | 1 | 349
|
| 198 | 14736 Levy YS, Gilgun-Sherki Y, Melamed E, Offen DBIODRUGS. 2005; 19 (2): 97-127
| 5 | 22 | 35 | 347
|
| 199 | 6511 Prusiner SBPROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 1998 NOV 10; 95 (23): 13363-13383
| 203 | 2566 | 7 | 346
|
| 200 | 16889 Thakker DR, Hoyer D, Cryan JFPHARMACOLOGY & THERAPEUTICS. 2006 MAR; 109 (3): 413-438
| 1 | 19 | 14 | 346
|